TXG logo

10x Genomics (TXG) Accounts receivable

Annual accounts receivable:

$87.86M-$26.97M(-23.49%)
December 31, 2024

Summary

  • As of today (May 24, 2025), TXG annual accounts receivable is $87.86 million, with the most recent change of -$26.97 million (-23.49%) on December 31, 2024.
  • During the last 3 years, TXG annual accounts receivable has risen by +$2.61 million (+3.06%).
  • TXG annual accounts receivable is now -23.49% below its all-time high of $114.83 million, reached on December 31, 2023.

Performance

TXG Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

Quarterly accounts receivable:

$52.55M-$35.31M(-40.19%)
March 31, 2025

Summary

  • As of today (May 24, 2025), TXG quarterly accounts receivable is $52.55 million, with the most recent change of -$35.31 million (-40.19%) on March 31, 2025.
  • Over the past year, TXG quarterly accounts receivable has dropped by -$38.76 million (-42.45%).
  • TXG quarterly accounts receivable is now -89.07% below its all-time high of $480.74 million, reached on March 1, 2016.

Performance

TXG Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TXG Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.5%-42.5%
3 y3 years+3.1%-31.3%
5 y5 years+163.3%+70.3%

TXG Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.5%+3.1%-54.2%at low
5 y5-year-23.5%+163.3%-54.2%+131.2%
alltimeall time-23.5%+558.6%-89.1%+131.2%

TXG Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$52.55M(-40.2%)
Dec 2024
$87.86M(-23.5%)
$87.86M(+5.2%)
Sep 2024
-
$83.53M(-8.4%)
Jun 2024
-
$91.18M(-0.1%)
Mar 2024
-
$91.31M(-20.5%)
Dec 2023
$114.83M(+10.2%)
$114.83M(+10.6%)
Sep 2023
-
$103.85M(+18.4%)
Jun 2023
-
$87.69M(+12.5%)
Mar 2023
-
$77.94M(-25.2%)
Dec 2022
$104.21M(+22.2%)
$104.21M(+24.7%)
Sep 2022
-
$83.55M(+9.6%)
Jun 2022
-
$76.20M(-0.4%)
Mar 2022
-
$76.53M(-10.2%)
Dec 2021
$85.25M(+66.5%)
$85.25M(+8.7%)
Sep 2021
-
$78.43M(+31.4%)
Jun 2021
-
$59.68M(+4.0%)
Mar 2021
-
$57.41M(+12.1%)
Dec 2020
$51.21M
$51.21M(+42.1%)
DateAnnualQuarterly
Sep 2020
-
$36.03M(+58.5%)
Jun 2020
-
$22.73M(-26.3%)
Mar 2020
-
$30.85M(-7.6%)
Dec 2019
$33.37M(+18.8%)
$33.37M(+27.6%)
Sep 2019
-
$26.15M(-2.4%)
Jun 2019
-
$26.80M(-4.6%)
Dec 2018
$28.09M(+110.5%)
$28.09M(-94.1%)
Dec 2017
$13.34M
-
Sep 2017
-
$480.03M(+2.1%)
Jun 2017
-
$470.13M(-2.1%)
Mar 2017
-
$480.17M(+7.0%)
Dec 2016
-
$448.58M(+5.8%)
Sep 2016
-
$424.00M(-0.7%)
Jun 2016
-
$427.06M(-11.2%)
Mar 2016
-
$480.74M(+2.3%)
Dec 2015
-
$470.12M(+24.2%)
Sep 2015
-
$378.41M(-12.8%)
Mar 2015
-
$433.74M

FAQ

  • What is 10x Genomics annual accounts receivable?
  • What is the all time high annual accounts receivable for 10x Genomics?
  • What is 10x Genomics annual accounts receivable year-on-year change?
  • What is 10x Genomics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for 10x Genomics?
  • What is 10x Genomics quarterly accounts receivable year-on-year change?

What is 10x Genomics annual accounts receivable?

The current annual accounts receivable of TXG is $87.86M

What is the all time high annual accounts receivable for 10x Genomics?

10x Genomics all-time high annual accounts receivable is $114.83M

What is 10x Genomics annual accounts receivable year-on-year change?

Over the past year, TXG annual accounts receivable has changed by -$26.97M (-23.49%)

What is 10x Genomics quarterly accounts receivable?

The current quarterly accounts receivable of TXG is $52.55M

What is the all time high quarterly accounts receivable for 10x Genomics?

10x Genomics all-time high quarterly accounts receivable is $480.74M

What is 10x Genomics quarterly accounts receivable year-on-year change?

Over the past year, TXG quarterly accounts receivable has changed by -$38.76M (-42.45%)
On this page